Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives

被引:51
作者
Wang, Tao [1 ]
Kadow, John F. [1 ]
Zhang, Zhongxing [1 ]
Yin, Zhiwei [1 ]
Gao, Qi [2 ]
Wu, Dedong [2 ]
Parker, Dawn DiGiugno [3 ]
Yang, Zheng [4 ]
Zadjura, Lisa [4 ]
Robinson, Brett A. [5 ]
Gong, Yi-Fei [5 ]
Blair, Wade S. [5 ]
Shi, Pei-Yong [5 ]
Yamanaka, Gregory [5 ]
Lin, Pin-Fang [5 ]
Meanwell, Nicholas A. [1 ]
机构
[1] Bristol Myers Squibb Co, Res & Dev, Dept Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Res & Dev, Dept Analyt Res & Dev, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Res & Dev, Dept Pharmaceut, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Res & Dev, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA
[5] Bristol Myers Squibb Co, Res & Dev, Dept Virol, Wallingford, CT 06492 USA
关键词
HIV; HIV attachment; gp120; Piperazine; A(1,3) strain; VIRUS ENTRY INHIBITORS; CD4; RECEPTOR-BINDING; CONFORMATIONAL-CHANGES; VIRAL ENVELOPE; CRYSTAL; BMS-378806; DISCOVERY; DIAMINES; TARGETS; GP120;
D O I
10.1016/j.bmcl.2009.07.076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-Fluoro- and 4-methoxy-1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl) ethane-1,2-dione (2 and 3, respectively) have been characterized as potent inhibitors of HIV-1 attachment that interfere with the interaction of viral gp120 with the host cell receptor CD4. As part of an effort to understand fundamental aspects of this pharmacophore, discovered originally using a high throughput cell-based screen, modification and substitution of the piperazine ring was examined in the context of compounds 6a-ah. The piperazine ring was shown to be a critical element of the HIV-1 attachment inhibiting pharmacophore, acting as a scaffold to deploy the indole glyoxamide and benzamide in a topographical relationship that complements the binding site on gp120. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5140 / 5145
页数:6
相关论文
共 36 条
[1]  
ANDREWS PR, 1988, J CHEM SOC P2, V2, P711
[2]   The mono-functionalization of symmetrical polyamines [J].
Bender, JA ;
Meanwell, NA ;
Wang, T .
TETRAHEDRON, 2002, 58 (16) :3111-3128
[3]  
Blair W., 2001, World Patent Application, Patent No. [WO-2001/96610, 200196610]
[4]  
Blair W. S., 2000, PCT Int. Appl, Patent No. [W02000076521A1, 200076521]
[5]   Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis [J].
Brameld, Ken A. ;
Kuhn, Bernd ;
Reuter, Deborah C. ;
Stahl, Martin .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (01) :1-24
[6]   New software for searching the Cambridge Structural Database and visualizing crystal structures [J].
Bruno, IJ ;
Cole, JC ;
Edgington, PR ;
Kessler, M ;
Macrae, CF ;
McCabe, P ;
Pearson, J ;
Taylor, R .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2002, 58 :389-397
[7]   Allylstannation of N-acyliminium intermediates:: a possible method for the stereocontrolled synthesis of polyhydroxypiperidines [J].
Chevallier, F ;
Beaudet, I ;
Le Grognec, E ;
Toupet, L ;
Quintard, JP .
TETRAHEDRON LETTERS, 2004, 45 (04) :761-764
[8]   Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV [J].
De Clercq, Erik .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (04) :307-320
[9]  
FUKUSHI H, 1994, CHEM PHARM BULL, V42, P551
[10]   Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions [J].
Guo, Q ;
Ho, HT ;
Dicker, I ;
Fan, L ;
Zhou, NN ;
Friborg, J ;
Wang, T ;
McAuliffe, BV ;
Wang, HGH ;
Rose, RE ;
Fang, H ;
Scarnati, HT ;
Langley, DR ;
Meanwell, NA ;
Abraham, R ;
Colonno, RJ ;
Lin, PF .
JOURNAL OF VIROLOGY, 2003, 77 (19) :10528-10536